Analysts' ratings for Celanese CE over the last quarter vary from bullish to bearish, as provided by 8 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 3 | 2 | 1 | 0 |
Last 30D | 0 | 2 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 1 | 1 | 1 | 0 |
3M Ago | 1 | 0 | 1 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $162.5, a high estimate of $180.00, and a low estimate of $135.00. This current average reflects an increase of 11.63% from the previous average price target of $145.57.
Exploring Analyst Ratings: An In-Depth Overview
In examining recent analyst actions, we gain insights into how financial experts perceive Celanese. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Ghansham Panjabi | Baird | Raises | Outperform | $165.00 | $135.00 |
Michael Sison | Wells Fargo | Raises | Overweight | $180.00 | $167.00 |
Hassan Ahmed | Alembic Global | Announces | Neutral | $160.00 | - |
Steve Byrne | B of A Securities | Raises | Underperform | $135.00 | $124.00 |
Joshua Spector | UBS | Raises | Buy | $170.00 | $169.00 |
Aleksey Yefremov | Keybanc | Raises | Overweight | $176.00 | $150.00 |
Joshua Spector | UBS | Raises | Buy | $169.00 | $144.00 |
Patrick Cunningham | Citigroup | Raises | Neutral | $145.00 | $130.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Celanese. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Celanese compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Celanese's stock. This analysis reveals shifts in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Celanese's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Celanese analyst ratings.
Delving into Celanese's Background
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Key Indicators: Celanese's Financial Health
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Negative Revenue Trend: Examining Celanese's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -5.66% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Celanese's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 27.17% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Celanese's ROE excels beyond industry benchmarks, reaching 10.28%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Celanese's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.68% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Celanese's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.98, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Analyst Ratings: Simplified
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.